Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical (LFCR) Raw Materials: 2012-2018

Historic Raw Materials for Lifecore Biomedical (LFCR) over the last 7 years, with May 2018 value amounting to $15.3 million.

  • Lifecore Biomedical's Raw Materials rose 10.42% to $14.6 million in Q4 2018 from the same period last year, while for Nov 2018 it was $14.6 million, marking a year-over-year increase of 10.42%. This contributed to the annual value of $15.3 million for FY2018, which is 50.48% up from last year.
  • As of FY2018, Lifecore Biomedical's Raw Materials stood at $15.3 million, which was up 50.48% from $10.2 million recorded in FY2017.
  • In the past 5 years, Lifecore Biomedical's Raw Materials registered a high of $15.3 million during FY2018, and its lowest value of $9.9 million during FY2016.
  • Moreover, its 3-year median value for Raw Materials was $10.2 million (2017), whereas its average is $11.8 million.
  • In the last 5 years, Lifecore Biomedical's Raw Materials fell by 4.79% in 2015 and then skyrocketed by 50.48% in 2018.
  • Yearly analysis of 5 years shows Lifecore Biomedical's Raw Materials stood at $10.4 million in 2014, then dropped by 4.79% to $9.9 million in 2015, then decreased by 0.24% to $9.9 million in 2016, then rose by 3.07% to $10.2 million in 2017, then skyrocketed by 50.48% to $15.3 million in 2018.